Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% versus 3% hypertonic saline nebulization for hospitalized infants with acute bronchiolitis
IRCT20181006041252N4Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hypertonic saline and salbutamol in bronchiolitis (2 arms), sponsored by Sabzevar University of Medical Sciences. Primary endpoint: Modified Respiratory Assessment Score. Started Dec 2018; status: completed.
02
Drugs
hypertonic salinesalbutamol
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on IRCT20181006041252N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181006041252N4.